Javid Javdani is Pleased to Announce That He is the Featured Subject in the First of Two Recent Interviews

In an exclusive interview, Javid Javdani speaks about how connecting with customers and embracing community has affected the trajectory of his career.

SAN DIEGO, CALIFORNIA , UNITED STATES, April 9, 2021 /EINPresswire.com/ — Pharmacist and entrepreneur Javid Javdani is delighted to announce that he is the subject of a recent interview dealing with a wide variety of matters, ranging from the importance of word-of-mouth advertising to how the COVID-19 pandemic has affected his multiple small businesses.

In the beginning of the interview, which was published on March 16, 2021, Javid outlines exactly how he came to the point in his career he finds himself in today, stating that, after starting out exclusively as a pharmacist, he “took over a grocery store that became a real opportunity for growth.” Explaining that when he bought the store, it catered solely to the local Persian community and ignored the many other ethnic groups living close by, he elaborates, “I expanded the store to serve those people and they have really supported me and helped me grow.”

On the subject of growth, and how exactly he was able to expand his grocery store and then branch out to own a successful restaurant and catering service, Javid asserts that there’s no mystery to his methods, answering, “(w)hen it comes to expansion and advertising and getting more business, I truly believe that working with and giving back to your community really, really helps.” He goes on to advocate grass-roots and word-of-mouth advertising as superior to print ads. “I work with religious groups, including Jewish, Christian, and Muslim communities,” he says, adding “they see that my store is not something just to make a profit, but a company that also wants to support the community.”

Addressing how his various small businesses have dealt with the challenges posed by the spread of the coronavirus, Javid Javdani reacts optimistically, opining, “the trend of online ordering and delivering is very exciting.” He states further that the pandemic has caused him to re-evaluate his business model to incorporate even more community outreach, highlighting how his restaurant and catering company sent hot food to hospitals for a few days each week during the height of COVID-19. “That’s a great marketing tool, and it helps people,” he remarks.

To read this interview in its entirety or to view other fascinating interviews with Javid Javdani, people can visit his personal website.

About Javid Javdani:

Javid Javdani is a fully-licensed pharmacist and successful entrepreneur. He owns and operates Balboa International Market, a neighbourhood grocery store in San Diego that caters to local ethnic communities by stocking a wide variety of international and hard-to-find food items, as well as traditional and conventional groceries. Balboa International Market carries specialty products that originate from distant places like Iran, Russia, India, and a whole host of European and Middle Eastern countries. It carries Halal and Kosher foods, as well. Javid also owns a restaurant and catering business. He currently works a few days a week as a pharmacist, dedicating the remainder of his time to running his other businesses. Javid Javdani is proud to serve his community both in the culinary and hospitality sectors, as well as in his capacity as a pharmacist.

Javid Javdani
Pharmacist and Entrepreneur
Visit us on social media:

Source: EIN Presswire

Occupational Toxicology and Placing Worker Safety at the Forefront to be discussed at HPAPi Conference

SMi Group Reports: Key topics such as Occupational Toxicology and Placing Worker Safety at the Forefront to be discussed at SMi’s 5th Annual HPAPi Conference

LONDON, LONDON, UNITED KINGDOM, April 9, 2021 /EINPresswire.com/ — SMi Group are delighted to announce that the 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference will be taking place virtually on the 10 and 11 May 2021. The two-day programme offers peer-to-peer networking opportunities with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more who will present on the several key topics being addressed, two that are particularly pertinent are Occupational Toxicology and Placing Worker Safety at the Forefront.

Interested parties can attend the conference by registering at £499 for pharmaceutical and biotechnology firms and £999 for vendors and commercial firms at http://www.highlypotentapi.com/PR4.

Sponsored by Catalent Pharma Solutions and FPS Food and Pharma Systems, this two-day agenda will have particular focus on Occupational Toxicology and Placing Worker Safety at the Forefront. Key presentations addressing these topics include the following:

Keynote Address: HPAPI – the dose makes the poison, covering:
• What is HPAPI
• What are Health Based Exposure Limits (HBELs)
• Regulatory application of HBELs in HPAPI manufacturing
Presented by: Ester Lovsin-Barle, Head of Product Stewardship and Health, Takeda

Containment Verification Testing for Pharmaceutical Equipment Performance, covering:
• Overview of ISPE Guide – Assessing the Particulate Containment Performance of Pharmaceutical Equipment (APCPPE)
• Applying the APCPPE Guide to various pharmaceutical equipment and containment systems
• Several Case Studies
Presented by: George Petroka, Principal, Director BioPharma/EHS Services, IES Engineers

Sponsor Led: Process equipment design for HPAPI containment system integration, covering:
• Are all standard Process Equipment suitable to safe handle HPAPI?
• Process Equipment critical analysis for high containment system integration
• Case studies
• Conclusions and new challenges
Presented by: Stefano Butti, Sales Director, FPS Food And Pharma Systems

A strategy in high potent compounds EHS and quality aspects, covering:
• Permitted Daily Exposure (PDE) calculations
• Evaluation of PDE compared to older standards for GMP cleaning limits
• Guidance currently available for setting toxicological evaluations
• Considerations within OEL setting for manufacturing plants from a legal background
Presented by: Reinhold Maeck, Associate Director, Tech Transfers, Boehringer Ingelheim

Hazard identification and assessment in a HPAPI environment, covering:
• Identifying potential routes of exposure to highly potent APIs
• OH exposure risk assessment and improvement projects
• PIE – Manufacturing Effluent Management
• Translating hazard assessments into appropriate engineering controls
• Strategies for effective containment improvement
Presented by: Olindo Lazzaro, Director Global EHS, AbbVie

This is an essential conference for those wanting to hear the latest insights and updates from industry leading experts in the field.

The full agenda, speaker line-up and brochure can be viewed online at http://www.highlypotentapi.com/PR4.

Sponsored by: Catalent Pharma Solutions & FPS Food and Pharma Systems
To join the conference as a sponsor and exhibitor, please get in touch with Alia Malick, Director on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference
10–11 May 2021
Virtual Conference: Online Access Only


About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk.

Simi Sapal
SMi Group
email us here

Source: EIN Presswire

Bridger Photonics’ LiDAR Technology Selected by ExxonMobil for EPA Methane Detection

This image shows LiDAR imaging of a methane plume coming from a production site, which is an example of Bridger Photonics technology.

An example of Bridger Photonics’ Gas Mapping LiDAR technology

This application is a massive breakthrough for the oil and gas industry and for Bridger. We are thrilled to be a part of it. All the hard work and innovation from our amazing team has paid off.”

— Pete Roos, CEO

BOZEMAN, MONTANA, UNITED STATES, April 9, 2021 /EINPresswire.com/ — Today, Bridger Photonics’ Light Detection and Ranging (LiDAR) technology was selected by ExxonMobil for incorporation into the first-ever filing of an application with the U.S. Environmental Protection Agency (EPA) to use cutting-edge technology for methane emissions and other regulatory compliance.

EPA Regulations (40 CFR Part 60 Subpart OOOOa) require oil and gas producers to inspect their equipment for leaks of methane volatile organic compounds and other pollutants. The regulation prescribes that field crews must visit hundreds of thousands of U.S. production sites on foot and inspect each piece of equipment by hand in search of leaks. While this leak detection process was considered the best available at the time, it is costly and time consuming, and has increased field crews’ exposures to on-site hazards.

Bridger Photonics was selected after an extensive vetting process including field trials of emerging methane detection technologies to identify more efficient, and more effective ways to detect and quantify methane leaks.

Instead of visiting sites on foot, Bridger Photonics scans sites from aircraft using its advanced LiDAR technology, Gas Mapping LiDAR™, to sensitively and quickly detect and estimate methane emissions throughout the entire natural gas value chain (production, transmission, and distribution of natural gas). Bridger hands its clients a map that pinpoints (GPS coordinates), images, and estimates the quantity of every detectable emission in the client’s infrastructure. These data products provide actionable information for field crews to easily find and prioritize leaks.

“What used to take six months for field crews to inspect now takes a matter of days with Gas Mapping LiDAR™,” said Dr. Pete Roos, CEO and co-founder of Bridger Photonics. “Bridger precisely locates and accurately quantifies methane emissions across broad areas so operators only need to deploy field crews when a leak is detected. This is a win-win for everyone involved: Bridger enables responsible operations while saving operators the cost and hazards of unnecessary visits to 60% to 90% of their sites.”

“We look forward to the EPA process establishing this alternative as equally effective as existing regulatory requirements. Our experience shows us the technology available today can detect leaks more efficiently than the manual processes federal regulations now require,” said Bart Cahir, senior vice president of unconventional at ExxonMobil. “ExxonMobil is deploying next-generation detection technologies under real-world operating conditions as part of our overall commitment to reduce methane emissions in our operations.”

Bridger Photonics’ Gas Mapping LiDAR™ is the first technology ever included in, and ExxonMobil is the first company ever to file, an application for an Alternate Means of Emissions Limitation (AMEL) for the EPA regulation. The AMEL application aims to replace ground crew visits with Gas Mapping LiDAR™.

“This AMEL application represents a massive breakthrough for the oil and gas industry and for Bridger. We are thrilled to be a part of it. All the hard work and innovation from our amazing team has paid off,” Roos added.

Bridger Photonics’ developed Gas Mapping LiDAR™ with funding from the US Department of Energy’s advanced research arm, ARPA-E, and won an R&D 100 award in 2019 recognizing the top 100 innovations worldwide for that year.

Pete Roos
Bridger Photonics
+1 406-585-2774
Visit us on social media:

Source: EIN Presswire

U.S. Patent Office Allows Patent for Alternative Environmental Technologies’ Sulfex™ Desulfurization Technology

This process has a lower capital investment, lower operating cost, lower carbon footprint and is safer than other desulfurization processes”

— Barry Dallum, VP Business Development

RENO, NV, U.S.A., April 8, 2021 /EINPresswire.com/ — Alternative Environmental Technologies (AET) has just been notified of the allowance of the U.S. Patent Office of another patent directed to its Sulfex™ Desulfurization Technology. The allowed patent demonstrates the continued evolution of its Sulfex™ technology.

AET’s Sulfex™ technology is a unique method of removing Sulfur from distillates. The method does not use high temperatures and pressures that are typically involved with conventional hydro-desulfurization processes and plants. Instead, Sulfex™ removes Sulfur from hydrocarbon fuels at substantially lower and safer temperatures and pressures. It eliminates CO2 emissions and toxic H2S generated by HDS processes. It does not use exotic, high maintenance precious metal catalysts nor does it utilize sometimes troublesome & high maintenance cavitation or ultrasonic process equipment.

By utilizing proprietary Sulfex™ solid and liquid catalysts coupled with an oxidizing agent, the Sulfur in the hydrocarbon fuel is converted to Sulfur species that can be easily stripped from the hydrocarbon fuel. The process achieves distillate fuel Sulfur levels less than 10 ppm, and produces a fuel which is ready for use. The process has been independently validated by the U.S. Department of Energy's Argonne National Labs (www.anl.gov) and the initial mass balance of the plant has also been reviewed and confirmed by a global engineering firm.

The intellectual property that is set forth in the latest allowed patent provides further enhancements to the Sulfex™ technology. By focusing further on the timing of the removal the Sulfur species as related to the reaction equilibrium, a further reduction in processing times and quantities of reagent and stripping constituents can now be achieved. Such advancements enhance an already efficient Sulfur removing process.

AET’s Vice President of Business Development, Barry Dallum stated “The progression of the patents we have obtained displays our commitment to our Sulfex desulfurization process to new fuels applications. This process has a lower capital investment, lower operating cost, lower carbon footprint and is safer than other desulfurization processes.”

About Alternative Environmental Technologies

Alternative Environmental Technologies (AET) is an environmental technology company dedicated to comprehensive cost-effective solutions to environmental problems centering on the processing and usage of hydrocarbons. With numerous worldwide patents and patent applications, AET is the worldwide master licensee of the world's most extensive emulsified fuel technology platform.

Using its protected technologies, AET has developed products that provide economical ways to address the increasingly stringent environmental and emission regulations globally to:

• Remove as much as 99.9% reductions of all sulfur compounds found in existing high sulfur fuels and middle distillates sourced from various refineries;
• Enhance combustion efficiency of fuel oil for industrial furnaces and boilers;
• Substitute water for expensive light distillates (i.e. diesel) in producing heavy fuel oil (HFO);
• Reduce Nitrogen Oxide (NOx) emissions, the key hurdle to global adoption of biofuel and biodiesel-based products; and
• Remove sulfur from petroleum in ways that are both more economical as well as more environmentally friendly than methods in current use.

For more information, please contact AET at info@alt-enviro-tech.com or by phone at +1 775 309 4555 or visit us online at www.alt-enviro-tech.com.

Steve G. Stevanovich
Alternative Environmental Technologies
+1 775 309 4555
email us here
Visit us on social media:

Source: EIN Presswire

Increased Use Of Disposable Medical Products Due To COVID-19 Leads To Demand In The Medical Waste Management Industry

Medical Waste Management Market Report 2021: COVID-19 Implications And Growth To 2030

Medical Waste Management Global Market Report 2021: COVID-19 Implications And Growth To 2030

The Business Research Company’s Medical Waste Management Global Market Report 2021: COVID-19 Implications And Growth To 2030

LONDON, GREATER LONDON, UK, April 8, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The rise in the use of disposable medical products in healthcare facilities is expected to drive the medical waste management market. In a healthcare setting, most of the products used are meant for single-use to limit cross-contamination among patients and decrease hospital-acquired infection. The use of single-use or disposal products surged due to the COVID-19 pandemic outbreak. The widely used disposables like surgical gloves, disposable bed sheets, masks, surgical gowns, syringes, intravenous saline bags, and others account for most of the hospital waste. Therefore, the rise in the use of disposable medical products is expected to drive the managing medical waste plant market.

Biomedical waste is generated during the diagnosis, treatment, and immunization of human beings or other living beings from healthcare facilities. The medical waste management market consists of the revenue generated from establishments providing services that include collection, transportation, storage, treatment, disposal, and recycling of such waste.

The medical waste management market covered in this report is segmented by type into bio-hazardous/infectious waste, non-hazardous waste, sharps, pharmaceutical, radioactive, others. The medical waste management market is also segmented by treatment into incineration, autoclaving, chemical treatment, others, by services into onsite services, offsite services, and by waste generator into hospitals, clinics, ambulatory surgical centers, pharmaceutical companies, biotechnology companies, others.

Read More On The Global Medical Waste Management Market Report:

The global medical waste management market size is expected to grow from $14.17 billion in 2020 to $14.56 billion in 2021 at a compound annual growth rate (CAGR) of 2.8%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The medical waste management market is expected to reach $18.18 billion in 2025 at a CAGR of 6%.

Major players in the medical waste industry are Waste Management (WM), Citiwaste, Sanpro Waste, MedPro Waste Disposal, Sharps Compliance, BioServeUSA, BioMedical Waste Solutions, PureWay Total Compliance, Medasend, and Veolia Environnement.

Medical Waste Management Global Market Report 2021: COVID-19 Implications And Growth To 2030 is one of a series of new reports from The Business Research Company that provides medical waste management market overview, forecast medical waste management market size and growth for the whole market, medical waste management market segments, and geographies, medical waste management market trends, medical waste management market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Medical Waste Management Market Report:

Here Is A List Of Similar Reports By The Business Research Company:

Hospital Supplies Global Market Report 2021: COVID-19 Implications And Growth to 2030

Environmental Consulting Services Market – By Types (Site Remediation Consulting Services, Water And Waste Management Consulting Services, Environment Management, Compliance And Due Diligence), By Region, Opportunities And Strategies – Global Forecast To 2021

Waste Management And Remediation Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Source: EIN Presswire

Graphalloy® Bushings Successful in Screw Compressor Pumps

Graphalloy Bushing

Graphalloy Bushing

These bushings are used in a process to compress gas

YONKERS, NY, USA, April 8, 2021 /EINPresswire.com/ — Graphite Metallizing Corporation, the manufacturer of self-lubricating GRAPHALLOY® bushing materials, announces the success of Graphalloy bushings in screw compressor pumps. Screw compressors act to compress gases using male and female rotors that rotate in opposite directions. As the gas progresses along the rotors it is compressed as the volume space between the rotors decreases, thereby creating compressed gas at the discharge.

In this particular application, Graphalloy Bushings are used in a screw compressor in dihydrogen gas service. It is a high speed, low load application for the bushings. They had originally tried aluminum bushings, which failed, then plain bronze bushings, which also failed. They then tried Graphalloy Bushings, which have been successful in this application.

Graphalloy Bushings offer solutions in places where traditional bearing lubricants will not work, including high temperature applications, clean environments, submerged operation applications, and more. The Graphalloy material is self-lubricating, non-galling, can handle low lubricity service and can withstand temperatures from -400°F (-240°C) to +1000°F (+535°C).

The Graphalloy material is used in many low lubricity pumps due to its self-lubricating and non-galling features, and screw compressors offer one more successful pump application for Graphalloy.

Graphalloy, a graphite-metal alloy, is available in over 100 grades with specific properties that meet a wide range of engineering solutions and specifications. Graphalloy bearings have operated for 20 years and longer in some applications. Common applications for Graphalloy bushings include pumps, wastewater, ovens, dryers, dampers/louvers, kilns, conveyors, submerged, and more.

FDA acceptable grades of Graphalloy are available for use in food service equipment. NSF® and WRAS grades of GRAPHALLOY material are also available for use in municipal well pumps and water treatment plant applications.

For a copy of one of our new catalogs, contact catalogs(at)graphalloy(dot)com.

For more information about Graphite Metallizing and its products, please visit us online at https://www.graphalloy.com or call +1-914-968-8400.

Eric Ford
Graphite Metallizing Corporation
+1 914-968-8400
email us here

Source: EIN Presswire

Registration Open for ComplianceOnline’s Event ‘Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment

"Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment – Issues and Solutions" Seminar has been added to ComplianceOnline.com's offering.

SAN JOSE, CA, UNITED STATES, April 8, 2021 /EINPresswire.com/ — Registration is now open for ComplianceOnline’s 2-day virtual seminar ‘Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment – Issues and Solutions’. Barry A. Friedman, Ph.D. will be the speaker for this virtual event on April 29-30, 2021 (10:00 AM to 4:00 PM EDT).

Raw material requirements in a cGMP environment are often overlooked as a Company develops new products. Depending upon the product being developed, e.g., tablets and capsules vs. biotechnology products to include recombinant microorganisms and gene therapy products, as few as fifteen to twenty or as many as sixty raw materials need to be sourced before the process can be moved from initiation through completion.

This highly interactive two-day seminar on raw material requirements in a cGMP environment will:

• Compare and Contrast FDA, Health Canada, ICH, USP and EP requirements
• Review latest updates to include FDA, Health Canada, ICH, USP and EP requirements
• Examine a variety of the issues surrounding raw materials to include what materials should be tested and to what extent during Phase 1, 2, 3 and commercial production.
• Cover testing requirements during each Phase (Phase appropriate), to include microbial and endotoxin, and what may be optional (regulatory risk) until the product moves to its next Phase.
• Determine what options exist – even within a Phase 2 or Phase 3 testing framework.
• Discuss compendial vs. non-compendial testing and how to respond when no method is available.
• Discuss how a 90 percent vs. a 90.0 percent minimum purity analysis can delay initiation of testing.
• Explore the number of lots required for testing before reduced testing might occur and why some companies don't accept this route.
• Review the use of individual samples vs. composite samples for testing.
• Review packaging and storage requirements and their impact on in-coming materials to include both raw materials and API.
• Explore ASQ testing to include how to choose attributes and sample size.
• Determine when the ASQ vs. square root of N+1 is appropriate.

The objective of this FIVE HOUR/DAY, ON-LINE two day highly interactive ComplianceOnline seminar is to explore raw materials and their requirements – issues and solutions. It will also explore how water impacts the final product since water is the single largest raw material that is used within most processes. Another objective is to assure that organizations maintain themselves within a cGMP compliance framework to include ICH Q7, Q9 and Q11. Case studies to include Warning Letters will be discussed to illustrate regulatory raw material issues.

Learning Objectives:

Upon completing this course on raw material requirements in a cGMP environment participants will:

• Understand how various types of raw materials may impact the user.
• Learn of the impact of raw materials to include any bacterial and endotoxin issues in the timely production of a product.
• Determine the single most used raw material in large molecule production and what it means to the user.
• Find the sources of analyses assistance for raw materials.
• Appreciate the requirements for Phase 1 through commercial manufacturing—why safety is required as part of Phase 1
• Initiation of additional testing — when?
• Examination of regulatory risk to include ICH Q7, Q9 and Q11.
• Why use compendial testing in lieu non-compendial testing.
• Testing requirements — when is enough?
• Understand packaging and storage requirements and their impact on in-coming materials to include both raw materials and API.
• The impact of ASQ vs. square root of N+1 on sample size and attribute testing.

Who Will Benefit:

Those who will benefit from this ON-LINE seminar include:

• Quality professionals
• Regulatory professionals
• Compliance professionals
• Manufacturing engineers
• Quality engineers
• Quality auditors
• Quality Control
• Microbiology
• In-coming Materials
• Document control specialists
• R & D
• Project Managers

For more information or to register for this seminar, please click here.
Virtual Training Through WebEx
Date: April 29-30, 2021 (10:00 AM – 4:00 PM EDT)

About the Speaker:

Barry A. Friedman, PhD, is a Consultant in the Biotechnology, Regulatory Compliance and Aseptic Processing Arena. Dr. Friedman possesses over 30 years of industrial managerial experience in various aspects of biopharmaceuticals and medical devices to include regulatory compliance, expert witness testimony, GLP/GMP, quality control, auditing, sterility assurance, microbiological/analytical validations and fermentation technology.

Prior to becoming an independent consultant, Dr. Friedman was associated with Cambrex Bio Sciences, a contract manufacturer of GMP bulk biopharmaceuticals located in Baltimore, Maryland. As the Director of Quality Control, he managed a multi-shift Department of thirty one individuals involved in client management, the receipt and testing of raw materials, environmental monitoring and microbiology, analytical chemistry and QC compliance for the production of Phase 1, 2, 3 and commercial products manufactured from bacteria, yeast and mammalian cells. In this capacity, Dr Friedman enjoyed many client and regulatory interactions, both domestic and international.

Prior to 2000, Dr. Friedman was the Laboratory Director for Chesapeake Biological Laboratories, a contract Aseptic Fill n’ Finish manufacturer located in Baltimore, Maryland. In addition to the professional history listed above, other associations have included W.R. Grace, Sigma Chemical Co., Sherwood Medical, Becton Dickinson, American Cyanamid and Union Carbide.

Dr. Friedman received his B.S. degree in Microbiology from Ohio State University, his M.S. from Michigan State University in Microbial Genetics, and his PhD from The Ohio State University in Microbiology.

About ComplianceOnline.com:

ComplianceOnline is a leading provider of regulatory compliance training programs for companies and professionals in regulated industries. ComplianceOnline has successfully trained over 55,000 professionals from 15,000 companies to comply with the requirements of regulatory agencies. ComplianceOnline is headquartered in Palo Alto, California, and can be reached at http://www.complianceonline.com. ComplianceOnline is a MetricStream portal. MetricStream (www.metricstream.com) is a market leader in Enterprise-wide Governance, Risk, Compliance (GRC), and Quality Management Solutions for global corporations.

For more information on ComplianceOnline or to browse through our training programs, please visit our website

Priyabrata Sahoo
email us here
Visit us on social media:

Source: EIN Presswire

Azelis Scales Up Digital Service Offerings With E-Lab Roll-Outs Well Underway

Azelis E-lab platform

The Azelis e-Lab is one of a kind. It’s a connecting experience that supports customers in creating and adapting formulations whilst providing easy access to a complete package of digital services.”

— Dr. Hans Joachim Müller, Azelis Chief Executive Officer

ANTWERP, ANTWERP, BELGIë, April 8, 2021 /EINPresswire.com/ — Azelis, an innovation service provider in the specialty chemicals and food ingredients distribution industry, is now scaling up its global e-Lab platform with the launch of its e-Lab for Personal Care and Food & Health customers in the United Kingdom and for Food & Health customers in Indonesia. In the coming months, more territories and market sectors will be onboarded on this global platform.

The launch of this platform is aligned with the company’s ambition to be the world-leading provider of digital services and insights in the industry, leading the way in customer engagement and making its e-Lab the engine for innovation through formulation. The roll-out of the Azelis e-Lab follows on the development of its global customer portal, a platform which allows easy access to Azelis’ product catalogue anytime, anywhere. Additionally, customers are able to order samples and place an order anytime and on any digital device.

Highlights & rationale

– In its ambition to become the world-leading innovation service provider for the specialty chemicals and food ingredients distribution, Azelis now launches a global e-Lab platform as a value-adding solution to enrich customers’ innovation capabilities.
– The Azelis e-Lab is an important addition to the company’s customer portal which offers a central place for its customers to access data, order samples and find expert content.
– Next to sustainability and innovation, digitalization is a key pillar in Azelis’ growth strategy.

The Azelis Americas e-Lab solution was the first digital chemicals platform of this kind in the market at the time of its launch and increased business performance for the Americas, with its optimization of customers’ time-to-market. Leveraging the success and learnings from the Americas, Azelis has now developed the e-Lab solution for global roll-out in multiple markets that will take place gradually over the coming months. The new, connected e-Lab solution provides fast access to formulation and ingredient recommendations, aligned with key feedback received from customers who were first onboarded. Through the Azelis e-Lab, customers will be able to define their formulation needs 24/7 and get access to Azelis’ global network of technical experts active in more than 60 labs globally.

In July 2020, Azelis launched its customer portal to the first markets to increase work efficiency and improve customer experience. Customers benefit from having one central place where they can access data about orders, samples, formulations, and expert content – all accessible anywhere and anytime. Azelis now proudly launches its e-Lab for Personal Care and Food & Health customers in the United Kingdom and for Food & Health customers in Indonesia. Following these, new launches will be stepped up significantly in the coming months.

Dr. Hans Joachim Müller, Azelis Chief Executive Officer, states:

“As part of our ambition to become a leader in digital offerings to the specialty chemicals and food ingredients distribution industry, we are continuously looking into new ways to connect and provide real-time assistance to our customers. The Azelis e-Lab is one of a kind. It’s a connecting experience that supports customers in creating and adapting formulations whilst providing easy access to a complete package of digital services. The combination of our extensive, global network of 60 application labs and application experts on the one side and our growing digital ecosystem on the other allows us to connect our experts with our customers and provide them the support they need anywhere, anytime and in the way they prefer.”

Heli Kilpala, Azelis group Strategy & Digitalization Director, adds:

“One year after the roll-out of our customer portal, the Digital Team at Azelis is incredibly proud to now launch the e-Lab platform to its customers. This digital solution includes a formulations database, an intuitive flow to provide requests, easy access to recommendations, and the possibility to connect with formulation experts to get assistance, advice, and discover new ways to innovate. We are excited to offer our customers a faster, easier and more encompassing path to their next innovation.”

In its aspiration to be the world-leading innovation service provider in the specialty chemicals and food ingredients distribution industry, Azelis has identified digitalization, innovation and sustainability as its growth drivers. Through Azelis’ connected solutions, the company is leading the way in customer engagement, whilst providing the digital insight that will drive new levels of chemical innovation. With its redefined sustainability strategy, Azelis is building a resilient, thriving and responsible business. Through these commitments, the company will meet the needs of its stakeholders, whilst also creating a positive and widespread impact on the environment and communities around the world. Innovation through formulation is Azelis’ passion and promise to every colleague, customer and partner, as the company combines products, ingredients and ideas – providing the expertise that will always matter in our changing world.

Learn more about the Azelis e-Lab here: https://solutions.azelis.com/elab/.

Sarah Van Alsenoy
+32 499 22 36 62
email us here
Visit us on social media:

Source: EIN Presswire

Sagacious IP Announces Free COVID-19 Vaccination Drive for Employees Globally

Sagacious IP Announces Free COVID19 Vaccination Drive for Employees Globally

Sagacious IP Logo

Sagacious IP logo

The vaccination drive will include all Sagacious IP employees globally along with their families.

GURUGRAM, INDIA, April 8, 2021 /EINPresswire.com/ — Sagacious IP, one of the largest global IP research and consulting firms, has decided to sponsor COVID-19 vaccines for its employees. The company took this decision to safeguard its employees in the wake of the pandemic and its adverse effects on mankind.

This voluntary vaccination drive for all employees of Sagacious IP involves vaccines approved by the Indian Government. Besides employees, this facility will also be extended to their families. In order to ensure a seamless process, Sagacious IP will be partnering up with various city-based authorities to provide end-to-end support and coordination.

“We, as a company, wish to encourage our employees and their families to get vaccinated through this voluntary vaccination drive in these uncertain times when the whole mankind is unsure about COVID-19’s cure. As per the government guidelines and procedures, Sagacious IP will follow all the protocols to carry out the vaccination drive as per phases”, said Tarun Kumar Bansal, President, Sagacious IP.

This move of launching a free vaccination drive is in line with the firm’s commitment to ensure the health and safety of its employees and their families and it would be over and above Sagacious IP’s existing medical insurance policy. Sagacious IP has played an integral role during the pandemic by launching its Free COVID-19 Research Assistance Program, through which it helped various companies battle shortage of masks, improve diagnostics, and expedite vaccination and cure for COVID-19.

All employees of Sagacious IP continue to work from home ever since the beginning of the pandemic. Further, the company plans to re-open its offices only after the voluntary vaccination drive to curb the spread of the disease.


About Sagacious IP
Sagacious IP is an award-winning IP research solutions provider working with the world’s largest companies, law firms, institutions, research organizations, and inventors to help them monetize, defend, and expand their patent portfolios and drive innovation within their industries. For more information visit: https://www.sagaciousresearch.com//

Sagacious Advanced Research Inc.
Sagacious Research Private Limited
+1 213-286-6088
email us here
Visit us on social media:

Source: EIN Presswire

STP and STC announce the release of its recently updated EHS protocol for Western Australia

Latest EHS Regulations Updates Assist Companies to Achieve EHS Compliance

VANCOUVER, BRITISH COLUMBIA, CANADA, April 7, 2021 /EINPresswire.com/ — STP ComplianceEHS (STP) and Specialty Technical Consultants (STC) announce the release of its recently updated EHS protocol for Western Australia.

This audit protocol, which covers relevant national EHS requirements, was previously updated in December 2018. The regulatory date for the current release is December 2020.

Leading companies around the world use EHS audit protocols to understand the scope of their EHS regulatory obligations and rapidly collect, share, archive, and export audit findings in a cost effective manner. EHS audit protocols are prepared by STC in partnership with STP and continue to focus on those national (plus, in some cases, regional or provincial) EHS requirements that have site-specific application for manufacturing operations. As a leading EHS management consulting firm with a global network of experienced EHS teaming partners, STC has in-depth knowledge and technical expertise of local/regional EHS requirements.

STP and STC maintain leading-edge EHS audit protocols for more than 50 jurisdictions. The protocol documents are written in English and are available in MS Word, Adobe Acrobat and Excel formats, as well as through STP’s web-based portal or can be integrated into an existing company platform. Using the protocols’ custom templates and advanced functionality features, auditors can easily track audit findings and manage data over time to improve compliance, risk management and safety performance. In addition, STP’s formatting is compatible with leading risk management and sustainability platform providers.

Highlights of selected legislation covered in the newly developed protocol include:

– The Dangerous Goods Safety (Storage and Handling of Non-Explosives) Regulations 2007 were amended in October 2020 by the Dangerous Goods Safety Regulations Amendment Regulations 2020. The term “subsidiary risk” was removed from the regulations and has been replaced by the term “subsidiary hazard.” In addition, references to the Australian Dangerous Goods (ADG) code have been updated.

– The Dangerous Goods Safety (Road and Rail Transport of Non-explosives) Regulations
2007 were amended in October 2020 by the Dangerous Goods Safety Regulations Amendment Regulations 2020. The amendments introduce new requirements with respect to dangerous goods packed in limited quantities and general precautions to be taken by prime contractors.

– The national Ozone Protection and Synthetic Greenhouse Gas Management Regulations 1995 were updated to incorporate new rules for charging refrigeration and air conditioning equipment which came into force on 1 January 2020 to support the hydrofluorocarbon (HFC) phase down and reduce emissions of climate damaging HFCs. The new rules ban charging of refrigeration and air conditioning equipment with a higher global warming potential (GWP) refrigerant than the equipment was designed to use, with an exception for refrigeration or air conditioning equipment that is essential for health or public safety purposes where the design refrigerant is not available.

– The national Product Emissions Standards Rules 2017 were updated to delay the commencement of the prohibition on supplying an emissions-controlled product that was due to commence on 1 July 2019 for 12 months, until 1 July 2020. The delay will allow an additional 12 months for suppliers and retailers to sell uncertified stock that was imported before the commencement of the import prohibition. Under the Product Emissions Standard Rules, certain propulsion marine engines and non-road engines are designated as “emissions-controlled products” which must be certified as meeting the Australian emissions standard, or a recognized foreign standard, in order to be imported or supplied in Australia.

– The national Industrial Chemicals (Notification and Assessment) Act 1989 and the Industrial Chemicals (Notification and Assessment) Regulations 1990 were repealed and have been replaced by a new regulatory scheme for industrial chemicals under the Industrial Chemicals Act 2019 and the Industrial Chemicals (General) Rules 2019.

– The national Industrial Chemicals Act 2019 (assented to in March 2019) establishes a new regulatory scheme, the Australian Industrial Chemicals Introduction Scheme (AICIS), for the importation and manufacture (introduction) of industrial chemicals in Australia. The AICIS replaced the National Industrial Chemicals Notification and Assessment Scheme (NICNAS) on 1 July 2020. The AICIS establishes a new way of categorizing and introducing industrial chemicals that focuses the pre-introduction assessment on higher risk chemical introductions and provides streamlined introduction pathways for lower risk chemicals that are intended to reduce the regulatory burden for industry. It also focuses on post-introduction evaluation and monitoring to help maintain the protection of health and safety of the public, workers, and the environment.

– The national Industrial Chemicals (General) Rules 2019 (effective 1 July 2020) supports the new industrial chemicals regulatory scheme established by the Industrial Chemicals Act 2019. These Rules set forth the technical and operational details and the requirements introducers must meet, including the requirement to categorize their chemicals that are not listed on the Australian Inventory of Industrial Chemicals.

For more information on this release click here.

For more information on all International EHS audit protocols offered by STP click here.

About STP ComplianceEHS
STP ComplianceEHS (STP) produces technical resource guides covering environmental, health & safety, transportation, business practices, standards, and law, offering comprehensive guidance on key compliance and regulatory issues. STP is a division of Glacier Media Inc., a Canadian information communications company that provides primary and essential information in print, electronic and online media. Glacier’s Business and Professional Information Group publishes directories, technical manuals, research and development materials, medical education, electronic databases, investment information, and specialty websites.

About Specialty Technical Consultants
Specialty Technical Consultants, Inc. (STC) is a specialized management consulting firm working to enhance environmental health and safety (EHS) performance. Through its consulting services, STC partners with clients to strengthen management systems' design and implementation, and identifies needs and implements solutions to meet business objectives. Services provided include: EHS compliance support; risk assessment; EHS auditing; corporate responsibility and sustainability; EHS management systems development and implementation; EHS regulatory information tools; and EHS training.

STC is certified as a Woman-Owned Business Enterprise (WBE) by the Women’s Business Enterprise National Council (WBENC) and the Supplier Clearinghouse for the California Public Utilities Commission, and as a Disadvantaged Business Enterprise (DBE) by the California Department of Transportation (Caltrans) Disadvantaged Business Enterprise (DBE) Program.

Natalie Elster
STP ComplianceEHS
+1 604-983-3434
email us here
Visit us on social media:

Source: EIN Presswire